PhenomeX Inc. announced impairment of goodwill for the second quarter ended June 30, 2023. For the quarter, the company reported loss on impairment of goodwill was $16,557,000.
Bruker Cellular Analysis, Inc.
Equities
BLI
US0843101017
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+51.09% | 63.85B | |
-2.21% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.55% | 26.52B | |
-21.47% | 18.69B | |
+3.03% | 12.73B | |
+21.93% | 12.11B | |
+27.92% | 12.07B |